HQ Function

The headquarters served as the central hub for research and development, clinical operations, and corporate functions, driving the company's gene therapy programs.

Notable Features:

Likely located within a modern life sciences building or research park in New York, providing access to advanced laboratory facilities and collaborative spaces conducive to biotech research.

Work Culture:

As a clinical-stage biotechnology company, Prevail Therapeutics likely fostered an innovative, scientifically-driven, and patient-focused work culture. Employees were probably passionate about advancing gene therapies for unmet medical needs.

HQ Significance:

The New York City location offered access to a rich talent pool from leading academic and medical institutions, proximity to financial markets, and a vibrant biotech ecosystem.

Values Reflected in HQ: The headquarters likely reflected values of cutting-edge science, innovation, collaboration, and a commitment to addressing severe neurodegenerative diseases.

Location:

As an independent entity, Prevail Therapeutics' operations were primarily based in the United States. Following its acquisition by Eli Lilly and Company in 2021, Prevail's programs and expertise became part of Lilly's extensive global research, development, manufacturing, and commercial operations. Lilly has a significant presence in numerous countries worldwide, supporting clinical trials, drug development, and patient access to medicines on a global scale. Therefore, the work initiated by Prevail now benefits from and contributes to Lilly's global infrastructure for genetic medicines.

Street Address:

430 East 29th Street, Suite 1520

City:

New York

State/Province:

NY

Country:

USA